At molecular level, two main genomic abnormalities define two molecular subgroups of cribriform prostate cancers: SPOPmut, which is associated with CHD1 and MAP3K codeletions, and (ii) PTENloss, which is mutually exclusive with SPOPmut [33]. This evidence concerns the gene CHD1 and prostate cancer.